The BabySeq project in Boston has begun collecting data to quantify the risks and benefits of DNA sequencing at birth.
An emerging additive manufacturing technology could be fast and cheap enough to compete with conventional methods, but it faces materials-related challenges.
Genetically engineered mice treated for Middle East respiratory syndrome are disease-free, but it’s not yet clear if it will work for humans.
My virtual helper can be surprisingly lifelike, but she’s obsessed with meetings.
New diagnostics can find the DNA that drives a tumor, but evidence that they help patients is missing.
Backing from disparate investors such as General Motors and a vacuum maker has given the battery startup Sakti3 an unusual amount of momentum.
America’s communications infrastructure is finally getting some crucial upgrades because one company is forcing competition when regulators won’t.
The treatment for cancer is often as devastating as the disease itself.
A new treatment for infertility eventually could improve women’s prospects for having babies later in life.